SEC Form 4 · accession 0001140361-17-034455
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Mazelsky
Officer — Executive Vice President
Period of report
Sep 1, 2017
Accepted (ET)
Sep 6, 2017 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 1, 2017 | M | 2,366 | $0.00 | A | 19,535 | D | |
| Common Stock | Sep 1, 2017 | F | 1,180 | $154.98 | D | 18,355 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F2 | — | Sep 1, 2017 | M | 2,366 | D | — | — | Common Stock | 2,366 | 9,929 | D |
Explanation of responses
- F1Includes a total of 86 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2017 and June 30, 2017.
- F2These restricted stock units were granted to the reporting person on September 1, 2012. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock and vest in five equal annual installments, beginning on the first anniversary date of the date of grant. The number of restricted stock units reported was adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.
- F3Not applicable.